Accurate pathological diagnosis is crucial for optimal management of patients with cancer.
For the approximately 100 known tumour types of the central nervous system, standardization …

Despite decades of research, brain tumours remain among the deadliest of all forms of cancer.
The ability of these tumours to resist almost all conventional and novel treatments relates, …

The division of medulloblastoma into different subgroups by microarray expression profiling
has dramatically changed our perspective of this malignant childhood brain tumour. Now, …

Medulloblastoma is a form of brain cancer that mainly arises during infancy and childhood.
Our understanding of this disease has transitioned rapidly; what was once thought of as a …

Current therapies for medulloblastoma, a highly malignant childhood brain tumour, impose
debilitating effects on the developing child, and highlight the need for molecularly targeted …

Medulloblastoma is a highly malignant paediatric brain tumour currently treated with a
combination of surgery, radiation and chemotherapy, posing a considerable burden of toxicity to …

Historical risk stratification criteria for medulloblastoma rely primarily on clinicopathological
variables pertaining to age, presence of metastases, extent of resection, histological …

Medulloblastoma (MB) comprises a biologically heterogeneous group of embryonal tumours
of the cerebellum. Four subgroups of MB have been described (WNT, sonic hedgehog (…

… Collection and assembly of data: Giles W. Robinson, Brent A. Orr, Gang Wu, Sridharan
Gururangan, Tong Lin, Ibrahim Qaddoumi, Stewart Goldman, Michael D. Prados, Annick Desjardins …

Background Young children with medulloblastoma have a poor overall survival compared
with older children, due to use of radiation-sparing therapy in young children. Radiotherapy is …